International Trade Bulletin - Volume 1, Issue 7
Client Alert | 2 min read | 06.12.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- CUSTOMS IN THE SPOTLIGHT
- REGULATIONS: Recent Regulations Proposed by Department of State Will Make U.S. Agency Regulators More Accountable for Regulatory Commitments Abroad
- PHARMACEUTICALS: Pharmaceutical Companies May Face Override of Patent Rights for Public Health Concerns
- FREE TRADE AGREEMENTS: Multi-National Firms Use Southeast Asian FTAs to Enter Indian Markets Demonstrating the Benefits of FTAs to Non-FTA Party Companies
- WTO: New Agreement Among WTO Members Could Allow Foreign Companies Greater Access to Taiwan's Government Procurement Market
- ANTI-DUMPING IN THE EU : European Commissioner for Trade, Peter Mandleson, announces review to decide the best way of balancing competing commercial interests in enforcing EU anti-dumping policy
- EXPORT CONTROLS: BIS Reaffirms Deemed Export Rules By Formally Withdrawing Advance Notice of Proposed Rulemaking
- C-TPAT: C-TPAT Establishes Mandatory Security Link Portal
Contacts
Insights
Client Alert | 4 min read | 12.04.25
District Court Grants Preliminary Injunction Against Seller of Gray Market Snack Food Products
On November 12, 2025, Judge King in the U.S. District Court for the Western District of Washington granted in part Haldiram India Ltd.’s (“Plaintiff” or “Haldiram”) motion for a preliminary injunction against Punjab Trading, Inc. (“Defendant” or “Punjab Trading”), a seller alleged to be importing and distributing gray market snack food products not authorized for sale in the United States. The court found that Haldiram was likely to succeed on the merits of its trademark infringement claim because the products at issue, which were intended for sale in India, were materially different from the versions intended for sale in the U.S., and for this reason were not genuine products when sold in the U.S. Although the court narrowed certain overbroad provisions in the requested order, it ultimately enjoined Punjab Trading from importing, selling, or assisting others in selling the non-genuine Haldiram products in the U.S. market.
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
Client Alert | 11 min read | 12.01.25
